Carregant...
The PARP inhibitor ABT-888 potentiates darbazine-induced cell death in carcinoids
Monoagent DNA-alkylating chemotherapies like dacarbazine are among a paucity of medical treatments for advanced carcinoid tumors, but are limited by host toxicity and intrinsic chemoresistance through the base excision repair (BER) pathway via poly (ADP-ribose) polymerase (PARP). Hence, inhibitors o...
Guardat en:
| Publicat a: | Cancer Gene Ther |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5083201/ https://ncbi.nlm.nih.gov/pubmed/27632933 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cgt.2016.39 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|